Skip to content
S3167Senate2021-2022 SessionSame asA4527

Study ADHD Drugs in Kids

Official title

“Authorizes and directs the department of health to conduct a study on drugs prescribed for school age children with ADD and ADHD”

Sponsor Kevin S. ParkerSD-21Affects Health
Status
In Senate Committee
Health
Impact
2/10
Minimal
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill directs the New York State Department of Health to study the effects and diagnosis rates of drugs prescribed for ADD and ADHD in school-age children.

Why it matters

  1. Examines potential risks. The bill ensures a focused investigation into possible harmful side effects of commonly prescribed medications for ADD and ADHD in children, which could impact medical guidelines, parental choices, and classroom management.

  2. Scrutinizes diagnostic practices. By analyzing how ADD and ADHD are being diagnosed—including the tools and methods used—it could highlight overdiagnosis or underdiagnosis, influencing future training for educators and clinicians.

  3. Addresses medication appropriateness and disparities. The study will look at whether certain drugs are being prescribed appropriately and if there are demographic disparities (e.g., by race, gender, or socio-economic status) in diagnosis or treatment, which could lead to policy changes for more equitable healthcare.

  4. Informs future policy and parental awareness. The findings will be reported directly to state leadership, potentially shaping statewide education and health policy and giving parents and schools more information about the medical and social implications of current practices.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Study ADHD Drugs in Kids

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Kevin S. Parker

Senator · Senate District 21

Chair, Energy And Telecommunications

No co-sponsors yet.

History

  1. Referred to health
  2. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A4527Assembly

Study ADHD Meds in Schools

In Assembly Committee · Health · Sponsor Latrice Walker

Impact 3 · Low0% to pass

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

3167

2021-2022 Regular Sessions

IN SENATE

January 28, 2021

Introduced by Sen. PARKER -- read twice and ordered printed, and when printed to be committed to the Committee on Health

AN ACT authorizing and directing the department of health to do research and study as to the effects of psychostimulants, selective seratonin reuptake inhibitors, antidepressants and other drugs which are prescribed for attention deficit disorders, ADD and ADHD, for school age children

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. 1. The commissioner of health, in conjunction with the commissioner of mental health, the commissioner of developmental disabilities, and the commissioner of education is authorized and directed to conduct a study and do research as to the effect of psychostimulants, selective serotonin reuptake inhibitors, antidepressants and other drugs prescribed for attention deficit disorder, attention deficit hyperactivity disorder, and the increasing rate of diagnosis of these conditions, in school age children.

2. The study shall be conducted in accordance with rules, regulations and standards determined by the commissioner of health, and the study shall concentrate on harmful side effects of such drugs, the appropriateness and effectiveness of tools and methods used to assess and diagnose the condition, the appropriateness of different medications, and any demographic disparities in diagnosis.

3. The commissioner of health shall report his or her findings to the governor, the speaker of the assembly and the temporary president of the senate on or before two years from the date this act shall take effect.

§ 2. This act shall take effect immediately.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD07287-01-1

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act authorizing and directing the department of health to do research and study as to the effects of psychostimulants, selective seratonin reuptake inhibitors, antidepressants and other drugs which are prescribed for attention deficit disorders, ADD and ADHD, for school age children

Purpose or general idea of the bill

To conduct a study on drugs prescribed for school-age children with ADD and ADHD, making recommendations thereafter.

Summary of specific provisions

Authorizes the commissioner of health, in conjunction with the commis- sioner of mental health, the commissioner of Developmental Disabilities and the commissioner of education to conduct a study and do research as to the effect of psycho stimulants, selective serotonin reuptake inhibi- tors, antidepressants and other drugs prescribed for ADD and ADHD, in school age children. The commissioner shall report his or her findings to the governor, the speaker of the assembly and the temporary president of the senate within two years that this act shall take effect.

Justification

Currently 5 million school kids in America are on psychotropic drugs. The Centers for Disease Control and Prevention (CDC) looked at drug overdose deaths among children ages 15 to 19 over a 16-year period, from 1999 to 2015, and showed that from 1999 to the mid-2000s drug overdose deaths in this age group more than doubled from 1.6 deaths per 100,000 in 1999 to 4.2 deaths per 100,000 in 2007).

Kids are routinely being misdiagnosed and forced to take drugs for behavior problems, often containing violent side effects. This problem is becoming an epidemic with no end in sight. It is imperative that the commissioner DOH performs a study on the effects of medicating our school children, and making recommendations thereafter.

Prior legislative history

2019-20: S2599- Referred to Health 2017-18: s2193 - Referred to Health 2015-16: S.2761 - Referred to Health 2013-14: S.3100 - Referred to Health 2011-12: S.1172 - Referred to Health 2009-10: S.8202/A.5602 - Passed Both Houses, Vetoed Memo 6752 2008-09: A.5388 - Passed Assembly 2007-08: A.5388 - Passed Assembly 2006-07: A.5885A - Passed Assembly 2005-06: A.5885 - Health

Effective date

This act shall take effect immediately

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.